HAS
HAS
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
0
$0
Total Volume
$0
17 transactions
Net Activity
+$0
Net buying
Sentiment Rating
Neutral / BalancedCEO Conviction Index
No Recent Signal
Key Drivers
- •Balanced trading volume with net neutral buying and selling activity.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
HAS has an insider buy conviction of 50%, compared to the Unknown sector buy average of 50%.
Multiple Insiders
S - Sale Insiders
$0 total
Over the last 90 days, corporate insiders at HAS (HAS) engaged in a total of 17 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 0 were sales. The total volume of insider trading reached $0.
The net insider activity for HAS shows a net buying bias of $0. This activity represents a 50% buy ratio, suggesting that insiders are currently neutral on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (S - Sale Insiders), who traded 37.5K shares valued at $0 on Aug 31, 2026.
Quick Actions
Related News & Analyst Reports
Read original insights and educational research covering HAS and the Unknown sector.
The Biotech Executive Playbook: Tracking Clinical Phase SEC Filings
An empirical study on how clinical-stage biotech executives execute Form 4 open-market purchases ahead of trial data releases, outlining the regulatory gaps and alpha potential of clinical insider tracking.
a16z Capital Distributions vs. Open-Market Insider Buying: A 2026 Study
A 2026 empirical study comparing Andreessen Horowitz's in-kind share distributions to LPs against open-market insider purchases, revealing which signal better predicts 12-month price performance.
The Impact of Interest Rates on Insider Behavior: A Macro Analysis
When the Fed tightens, equity valuations fall, but insider purchase activity does not always follow the same pattern. This report examines three rate-hike cycles to show how rising rates affect the frequency and conviction of C-suite stock buys.
Insider Trading and Earnings Announcements: Spotting the Catalyst
How does insider trading activity in the 30 days before earnings compare to post-announcement prices? This study quantifies the predictive power of pre-earnings Form 4 purchases after accounting for blackout period compliance.
Evaluating a16z Web3 Spinoffs: Insider Activity in Tech Convergence Stocks
Andreessen Horowitz has backed dozens of Web3 startups that later went public. This report tracks board-member Form 4 activity at a16z-affiliated tech convergence companies to identify post-IPO insider conviction signals.
Unusual Insider Buying Patterns: Spotting the Anomalies
Beyond simple purchase screens, unusual insider buying patterns, accelerating purchase velocity, off-hours filings, purchases during active 10b5-1 plans, can reveal extraordinary conviction. This guide documents nine pattern types and their historical signal accuracy.
FAQs About HAS Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for HAS.